NAD(1-) (BioCAD00000476617)
{$topic}
Metabolite Card
Formula: C21H26N7O14P2 (662.1013)
SMILES: NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O
Synonyms [en]
NAD+; NAD; adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] diphosphate}; DPN+; nicotinamide adenine dinucleotide; coenzyme I
Last reviewed on 2024-06-28.
Cite this Page
NAD(1-). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000476617). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
An anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety." []
DBLinks
- CAS Registry Number: 53-84-9
- PubChem CID: 15938971
- ChEBI: 57540
- HMDB:
- LipidMaps:
- KEGG:
- BioCyc: NAD
- NCBI MeSH: NAD
- Wikipedia: Nicotinamide_adenine_dinucleotide
Other DBLinks
- CAS Registry Number: 53-84-9
- CAS Registry Number: 76961-04-1
- PubChem: 15938971
- ChEBI: ChEBI:57540
- BioCyc: NAD
- NCBI MeSH: NAD
- Wikipedia: Nicotinamide_adenine_dinucleotide
Class / Ontology
- ChEBI: [CHEBI:57540] NAD(1-)
| ID | EC Number | Name |
|---|---|---|
| BioCyc:FUMARATE-REDUCTASE-NADH-RXN | 1.3.1.6 | SUC + NAD<=>FUM + NADH + PROTON |
| BioCyc:HISTALDEHYD-RXN | HISTIDINAL + NAD + WATER --> 2 PROTON + HIS + NADH | |
| BioCyc:ALTRO-OXIDOREDUCT-RXN | 1.1.1.58 | PROTON + NADH + D-TAGATURONATE --> NAD + D-ALTRONATE |
| BioCyc:RXN-9657 | 1.3.1.9 | crotonyl-[acp] reductase |
| BioCyc:RXN-13158 | 1.1.1.85 | 2-D-THREO-HYDROXY-3-CARBOXY-ISOCAPROATE + NAD --> 2K-4CH3-PENTANOATE + CARBON-DIOXIDE + NADH |
| BioCyc:RXN-9662 | 1.3.1.9 | trans tetradec-2-enoyl-[acp] reductase |
| BioCyc:NAD-SYNTH-NH3-RXN | 6.3.1.5 | AMMONIUM + ATP + DEAMIDO-NAD --> PROTON + AMP + PPI + NAD |
| BioCyc:RXN-9663 | 1.3.1.9 | trans hexadecenoyl-[acp] reductase |
| BioCyc:GLYCOLALD-DEHYDROG-RXN | 1.2.1.21 | GLYCOLALDEHYDE + WATER + NAD --> GLYCOLLATE + NADH + 2 PROTON |
| BioCyc:DLACTDEHYDROGNAD-RXN | 1.1.1.28 | D-LACTATE + NAD<=>PYRUVATE + NADH + PROTON |
| BioCyc:DNA-LIGASE-NAD+-RXN | 6.5.1.6 | 3-Hydroxy-Terminated-DNAs + 5-Phospho-terminated-DNAs + NAD --> DNA-N + AMP + NICOTINAMIDE_NUCLEOTIDE + PROTON |
| BioCyc:PGLYCDEHYDROG-RXN | 1.1.1.95 | G3P + NAD<=>PROTON + 3-P-HYDROXYPYRUVATE + NADH |
| BioCyc:ACETALD-DEHYDROG-RXN | 1.2.1.10 | ACETALD + CO-A + NAD --> ACETYL-COA + NADH + PROTON |
| BioCyc:GLYCOLALDREDUCT-RXN | 1.1.1.77 | GLYCOL + NAD --> GLYCOLALDEHYDE + NADH + PROTON |
| BioCyc:HISTOLDEHYD-RXN | HISTIDINOL + NAD<=>PROTON + HISTIDINAL + NADH | |
| BioCyc:PREPHENATEDEHYDROG-RXN | 1.3.1.12 | PREPHENATE + NAD --> P-HYDROXY-PHENYLPYRUVATE + CARBON-DIOXIDE + NADH |
| BioCyc:DIMETHUROPORDEHYDROG-RXN | 1.3.1.76 | DIHYDROSIROHYDROCHLORIN + NAD --> 2 PROTON + SIROHYDROCHLORIN + NADH |
| BioCyc:RXN-9661 | 1.3.1.9 | trans dodec-2-enoyl-[acp] reductase |
| BioCyc:LACTALDREDUCT-RXN | 1.1.1.77 | PROPANE-1-2-DIOL + NAD<=>LACTALD + NADH + PROTON |
| BioCyc:GAPOXNPHOSPHN-RXN | 1.2.1.12 | GAP + Pi + NAD<=>PROTON + DPG + NADH |
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY-5453 | methylglyoxal degradation III |
| BioCyc:HUMAN_NAD-BIOSYNTHESIS-III | NAD salvage |
| BioCyc:HUMAN_NADPHOS-DEPHOS-PWY-1 | NAD phosphorylation and dephosphorylation |
| BioCyc:HUMAN_PWY66-367 | ketogenesis |
| BioCyc:HUMAN_PWY-6118 | glycerol-3-phosphate shuttle |
| BioCyc:HUMAN_PWY-5905 | hypusine biosynthesis |
| BioCyc:HUMAN_PWY-6535 | 4-aminobutyrate degradation |
| BioCyc:HUMAN_PWY-5177 | glutaryl-CoA degradation |
| BioCyc:HUMAN_PWY66-161 | oxidative ethanol degradation III |
| BioCyc:HUMAN_PWY66-414 | superpathway of choline degradation to L-serine |
| BioCyc:HUMAN_PWY-5695 | urate biosynthesis/inosine 5'-phosphate degradation |
| BioCyc:HUMAN_PWY-6872 | retinoate biosynthesis I |
| BioCyc:HUMAN_ILEUDEG-PWY | isoleucine degradation |
| BioCyc:HUMAN_PWY66-425 | lysine degradation II (pipecolate pathway) |
| BioCyc:HUMAN_TRYPTOPHAN-DEGRADATION-1 | tryptophan degradation |
| BioCyc:HUMAN_PWY-6307 | tryptophan degradation via tryptamine |
| BioCyc:HUMAN_PWY66-401 | superpathway of tryptophan utilization |
| BioCyc:HUMAN_PWY66-378 | androgen biosynthesis |
| BioCyc:HUMAN_PWY66-400 | glycolysis |
| BioCyc:HUMAN_PWY-7592 | arachidonate biosynthesis III (metazoa) |